tiprankstipranks
Sinopharm Group Co Ltd Class H (SHTDF)
OTHER OTC:SHTDF
US Market
SHTDF
Sinopharm Group Co
RESEARCH TOOLSreports
Want to see SHTDF full AI Analyst Report?

Sinopharm Group Co (SHTDF) Financial Statements

60 Followers

Sinopharm Group Co Financial Overview

Sinopharm Group Co's market cap is currently $7.34B. The company's EPS TTM is $2.27; its P/E ratio is 3.75; and it has a dividend yield of 3.82%. Sinopharm Group Co is scheduled to report earnings on April 27, 2026, and the estimated EPS forecast is $0.16. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue¥ 560.28B¥ 584.51B¥ 596.57B¥ 552.15B¥ 521.05B
Gross Profit¥ 40.15B¥ 44.26B¥ 48.51B¥ 47.43B¥ 44.05B
Operating Income¥ 16.24B¥ 16.19B¥ 20.21B¥ 20.60B¥ 19.71B
EBITDA¥ 20.41B¥ 20.17B¥ 26.90B¥ 26.25B¥ 24.68B
Net Income¥ 6.97B¥ 7.05B¥ 9.05B¥ 8.53B¥ 7.76B
Balance Sheet
Cash & Short-Term Investments¥ 61.59B¥ 54.31B¥ 63.81B¥ 55.22B¥ 43.54B
Total Assets¥ 390.53B¥ 392.83B¥ 383.39B¥ 364.78B¥ 335.41B
Total Debt¥ 108.63B¥ 76.39B¥ 73.78B¥ 69.59B¥ 68.37B
Net Debt¥ 47.04B¥ 22.07B¥ 9.97B¥ 14.37B¥ 24.84B
Total Liabilities¥ 256.31B¥ 266.14B¥ 263.08B¥ 254.71B¥ 235.76B
Stockholders' Equity¥ 83.99B¥ 78.88B¥ 74.58B¥ 68.07B¥ 61.89B
Cash Flow
Free Cash Flow¥ 12.52B¥ 9.58B¥ 14.84B¥ 18.55B¥ 7.05B
Operating Cash Flow¥ 14.14B¥ 11.55B¥ 17.17B¥ 20.96B¥ 9.31B
Investing Cash Flow¥ -963.89M¥ -3.75B¥ -944.53M¥ -3.59B¥ -1.27B
Financing Cash Flow¥ -18.69B¥ -17.29B¥ -7.64B¥ -5.69B¥ -14.69B
Currency in CNY

Sinopharm Group Co Earnings and Revenue History

Income Statement >

Sinopharm Group Co Debt to Assets

Balance Sheet >

Sinopharm Group Co Cash Flow

Cash Flow >

Sinopharm Group Co Forecast EPS vs Actual EPS

Earnings >